---
layout: post
title: "Mylan Pharmaceuticals Inc., et.al.; Withdrawal of Approval of 11 Abbreviated New Drug Applications"
date: 2026-02-05 18:35:45 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-04175
original_published: 2023-03-01 00:00:00 +0000
significance: 8.00
---

# Mylan Pharmaceuticals Inc., et.al.; Withdrawal of Approval of 11 Abbreviated New Drug Applications

**Published:** February 05, 2026 18:35 UTC
**Source:** Federal Register
**Original Published:** March 01, 2023 00:00 UTC
**Document Number:** 2023-04175

## Summary

The Food and Drug Administration (FDA or Agency) is withdrawing approval of 11 abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/03/01/2023-04175/mylan-pharmaceuticals-inc-etal-withdrawal-of-approval-of-11-abbreviated-new-drug-applications)
- API: https://www.federalregister.gov/api/v1/documents/2023-04175

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
